Educational Videos

Highlights from ACR 2020: COVID-19 and RA
Developed by CESAS Medical, under the auspices of the University of Glasgow. This activity is supported by unrestricted educational grants from Lilly, AbbVie, Gilead/Galapagos, and Pfizer

Release date: 04 December 2020
Estimated time to complete activity: 1 hour
Compatible with all modern internet browsers and mobile devices

EDUCATIONAL OBJECTIVES
After completing this activity, the learner will:

• Review the latest data on COVID-19 and its clinical impact on the treatment of rheumatic diseases

• Evaluate the latest data from ACR 2020 on JAK inhibitors in rheumatoid arthritis

TARGET AUDIENCE
This activity is designed for qualified rheumatologists of all levels of seniority, and other healthcare professionals involved in treating patients with inflammatory disease.

PROGRAMME OVERVIEW
Highlights from ACR 2020 presented new scientific and clinical information on infections and the clinical impact of COVID-19 on the treatment of rheumatic diseases, as well as the latest updates on JAK inhibitors in RA from ACR 2020.

In this activity, Highlights from ACR 2020: COVID-19 and RA, international experts review and discuss key abstracts and data from ACR 2020 specifically relating to cytokine signalling in RA. The two modules in this course highlights the latest data on infections and COVID-19 in rheumatic diseases, along with the updated long-term data on emerging and approved JAK inhibitors.

This course, Highlights from ACR 2020: COVID-19 and RA, outlines recent developments in cytokine signalling science in rheumatoid arthritis, and highlights and discusses the importance of these new data for clinical practice. The learner’s understanding of the information presented will be assessed following each of the course modules.

INSTRUCTIONS FOR PARTICIPATION
Participants must 1) read the activity information; 2) study the educational activity; 3) successfully complete the post-module assessments with a score of 80% or better; 4) and complete the evaluation form. Upon completion of the full activity, your certificate will be made available to download and print.

DISCLOSURE OF CONFLICTS OF INTEREST
CESAS Medical requires faculty, presenters, planners, managers, writers, and any other individuals who are in a position to influence the content of this activity to disclose any real and/or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly reviewed and resolved according to CESAS Medical policy.

ACCREDITATION STATEMENT
The e-learning activity, Highlights from ACR 2020: COVID-19 and RA, organised by CESAS Medical, under the auspices of the University of Glasgow, is accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to provide the following CME activity for medical specialists. The e-learning activity, Highlights from ACR 2020: COVID-19 and RA, organised by CESAS Medical, under the auspices of the University of Glasgow, is awarded 1 European CME credits (ECMECs).

Each medical specialist should claim only those credits that he/she actually spent in the educational activity. The EACCME is an institution of the European Union of Medical Specialists (UEMS). Only those e-learning materials that are displayed on the UEMS-EACCME website have formally been accredited. Through an agreement between the European Union of Medical Specialists (UEMS) and the American Medical Association (AMA), physicians may convert EACCME credits to an equivalent number of AMA PRA Category 1 Credits. Information on the process to convert EACCME credit to AMA credit can be found at www.ama-assn.org/education/earn-credit-participation-international-activities.